The European Commission's new Biotech Act aims to enhance the EU's biotechnology sector by creating a supportive framework for faster market entry, increased funding, and simplified regulations. It seeks to make Europe a global leader in biotech, addressing the current lag behind the US and China. Key measures include the Health Biotech Investment Pilot to mobilize €40 billion annually, streamlined clinical trial processes, extended patent protections, and the establishment of strategic labels for impactful biotech projects. Teljes cikk (Euronews.com)